这个论坛最没有逻辑的就是贵圈了, 天天吹IVM, 实际上印度95%以上的人都有抗体了, 和IVM没有半点关系。



有一种可能,

IVM用于感染初起,可以大幅度降低重症,死亡,

所以,IVM保驾,印度人慢慢都的过一遍了,但是并没有症状问题,所以印度没有显示出新的感染高峰。死亡更是大幅缩减。

这就是药物保护的共存的典型案例。

这一可能性是非常高的。

因为群免和疫苗都不是现在印度疫情低走的原因!


这都不能理解?

弱。

圈儿这个印度博主没好好做功课。印度早就不再推广 hcq / ivermectin。 因为没啥鸟用。 现在只限于 clinical trial

早说了,想当印度博主,先学会喝牛尿。不然就省省吧

 
最后编辑:

The Undeniable Ivermectin Miracle in India’s 240m Populated Largest State, Uttar Pradesh – Horowitz​

By
NewsRescue
-
September 15, 2021
https://www.facebook.com/sharer.php...pulated-largest-state-uttar-pradesh-horowitz/
https://twitter.com/intent/tweet?te...-state-uttar-pradesh-horowitz/&via=newsrescue
https://pinterest.com/pin/create/bu...lated+Largest+State,+Uttar+Pradesh+–+Horowitz
https://api.whatsapp.com/send?text=...pulated-largest-state-uttar-pradesh-horowitz/
https://reddit.com/submit?url=https...lated+Largest+State,+Uttar+Pradesh+–+Horowitz
https://telegram.me/share/url?url=h...lated+Largest+State,+Uttar+Pradesh+–+Horowitz
Pharmacy bottle with generic drug pills. 3D
Lazy eyes listen

  • Doctors advice that Ivermectin or Monoclonal antibodies should be used within the first 10 days of contact/infection; while the virus is still alive. After 10 days the virus is already dead and has left trillions of cascade-causing debris viral particles
NewsRescue
by DANIEL HOROWITZ, TheBlaze
Uttar Pradesh might sound obscure to most Americans, but it is the most populated state in India, with urban areas that rival the most densely populated cities in the U.S. Yet, miraculously, despite housing a population of 240 million people, this northern state has been averaging only 24 cases and 0-2 deaths per day in recent months. Despite its size — roughly 73% of the U.S. population — it ranked dead last in cases per capita last week among India’s 36 states. What gives?

The answer likely lies in the 10-letter “I-word” that you are not allowed to mention on social media: ivermectin. Evidently, the global medical junta doesn’t like the over 60 studies vouching for the efficacy of ivermectin against SARS-CoV-2, especially when used early, but there is something better than a study: pure reality of lived experience.
Screen-Shot-2021-09-15-at-11.55.37-AM-736x517.png
India’s Uttar Pradesh moving towards being Covid free, Ivermectin central to virus control
Last year, the northern state of Uttar Pradesh began dispensing ivermectin liberally and encouraging people to take it early on and even preventively. As Trial Site News reported earlier this year, “By the end of 2020, Uttar Pradesh — which distributed free ivermectin for home care — had the second-lowest fatality rate in India at 0.26 per 100,000 residents in December. Only the state of Bihar, with 128 million residents, was lower, and it, too, recommends ivermectin.”Don’t miss out on content from Dave Rubin free of big tech censorship. Listen to The Rubin Report now.
img.png

As you can see, COVID has been dead in Uttar Pradesh with the exception of a very brief six-week spike in the early spring. Uttar Pradesh likely would have been the first world experiment of what a given area would have looked like had they been taking ivermectin from day one before a wave hit. Unfortunately, hundreds of thousands of seasonal migrants fled Mumbai and other big cities when the Delta wave hit and all settled back in their villages in Uttar Pradesh, giving them the same spike that every other state got because those people were not on ivermectin. As the AP reported in mid-April, during the surge in Uttar Pradesh, many of these seasonal workers who work half the year in the big cities returned home to their villages. They were likely not taking ivermectin.
But when the state began distributing the drug to everyone, cases plummeted quicker and sharper than anywhere else we’ve seen in the world, and the gains have held for months with record low cases. Dr. Surya Kant Tripathi, head of the Respiratory Medicine Department, King George Medical University, Lucknow, told the Financial Express Online in April that the state began giving ivermectin to everyone who was in home isolation (rather than telling them to do nothing until they can’t breathe, like we do here in the United States).
Video: Dr. Paul Marik Discusses Ivermectin and Vitamin D
They also avoided use of the odious remdesivir. “All trials are saying that this drug is not effective in the treatment of COVID-19, rather it is complicating and resulting in mortality of patients,” said Dr. Tripathi. “At so many centers, remdesivir trials were stopped. Also, remdesivir is costing minimum of Rs 5,000 per vial.”
Overall, the death rate in Uttar Pradesh was roughly 95 per million people, roughly 1/20 the death rate of the U.S. More importantly, despite being the largest state in India, it incurred one-third the death rate of the country as a whole.
Take a look at this comparison between the death curve in Uttar Pradesh and the curve in India at large:
img.png
img.png

You will see that Uttar Pradesh experienced a plummeting of deaths more precipitous than India in the aggregate. Moreover, while cases and deaths in recent months have generally been pretty low in India because most people already got the virus, the pandemic is completely dead in Uttar Pradesh.
Screen-Shot-2021-09-15-at-11.56.22-AM-736x425.png
MSN: Uttar Pradesh government says early use of Ivermectin helped to keep positivity, deaths low
To put this comparison in another perspective, it took from May 9 to June 23 (45 days) for cases to decline 86% off the peak seven-day average for India at large. Not only did Uttar Pradesh peak earlier (April 27), it took just 30 days for it to achieve an 86% drop. By the 45-day window of comparison, cases in Uttar Pradesh had already dropped 98%. Today, it stands at 99.93% off the peak!
Now let’s compare this to the state of Kerala, which has removed ivermectin and other proven therapeutics from its treatment protocol and has gone all in on the ineffective remdesivir. Not only have cases not declined, but they have gone backward.
img.png

Remember, Kerala, at 34 million people, is just a fraction of the size of Uttar Pradesh.
Furthermore, just 4.5% of people in Uttar Pradesh are fully vaccinated, compared to 20% in Kerala. In this tiny state, already 70% of people 45 years and older and almost 56% of its population have had at least one shot.
Some might suggest that Kerala, being a southern state, is not a good comparison to the northern state of Uttar Pradesh because it is likely on a different epidemiological schedule. However, while Uttar Pradesh was the first state to use ivermectin, others have followed suit. Goa, which is a southern state, began offering ivermectin to all adults on May 11 and experienced a remarkable and durable decline.
img.png

Delhi, Karnataka, and Uttarakhand also used ivermectin widely and have basically eradicated the virus.
Thus, if anything, if we are to believe a government can force people to inject medicine into their bodies to stop the virus, governments everywhere would be following the science by a factor of 100 were they to mandate ivermectin rather than the vaccines. Everyone now agrees the vaccines do not stop transmission. The only question is how long the efficacy against serious illness lasts, for whom, and whether it broadly creates antibody dependent disease enhancement.https://playlist.megaphone.fm/?e=BMDC2861655210
We already have dozens of studies vouching for the efficacy of ivermectin. While the establishment likes to complain about the sample size of each one individually, as one study published in Nature noted, “The probability that an ineffective treatment generated results as positive for the 55 studies to date is estimated to be 1 in 23 trillion (p = 0.000000000000043).” The story of Uttar Pradesh and the other Indian states that used ivermectin certainly demonstrates this.
Ivermectin was regarded as a “wonder drug” responsible for virtually eradicating river blindness in Africa. Given its robust anti-viral and anti-inflammatory mechanisms of action, Uttar Pradesh is a living testament that it could have been used to wipe COVID off the map as well. Sadly, the Western world would rather bankrupt us and cause more deaths for politically driven solutions that don’t work than cede back to the people the control they’ve established. Perhaps there is a lot we can learn from the third world, for we are now seeing the growth of a “fourth world” mentality that is much more destructive than the third world.
 
圈儿这个印度博主没好好做功课。印度早就不再推广 hcq / ivermectin。 因为没啥鸟用。 现在只限于 clinical trial

早说了,想当印度博主,先学会喝牛尿。不然就省省吧

IVM工作已经完成了。看看曲线吧先。看看什么时候IVM开始发放,到9月中旬,病例数是不是已经触底。

你不想问问这中间发生了什么?

9月份抗体已经足够保护。印度当然不愿意得罪大厂。面子上要给。

而且实际上,你以为印度人买药需要向加拿大一样吗?

考虑问题要全面,不能停留在表面。
 
有些行业门槛很低,或者根本没有,可以速成,比如炒股,做议员,当总统等,做得水平高低,成果如何先不论,很多人都可以认为自己是最优秀的专家,比如那位懂王。

有些行业门槛很高,外行是绝不可能涉足的,除非是完全没有自知之明的人。比如懂王可以当总统,但是绝不可能当医生,法官。

这些行业需要资质,坚实的基础,是不可能速成的。无论天分多高,多么努力,靠读科普知识,看民科视频是无法上阵和邓亚萍,郭晶晶比试的。

这里少说有7,8位说过了,即使本专业专家也会有不同意见,所以不必盲目跟风,专家不一定完全正确,但是外行的长篇大论都不用去理会了,用本站时髦的话说,必定是千疮百孔,不值得一读。那些自鸣得意的创造性观点自己相信就好,实在没有必要强行推销。

医学,法律,环保等等方面我都是外行,也不打算去速成,最多是关注,围观新闻,数据等方面,不懂原理,因果关系。

总之,专家不一定都对,外行更不可能。
 
圈儿这个印度博主没好好做功课。印度早就不再推广 hcq / ivermectin。 因为没啥鸟用。 现在只限于 clinical trial

早说了,想当印度博主,先学会喝牛尿。不然就省省吧

哎。印度断崖,从五月中到9月中已经基本完成,不封城,高密度人口,怎么断崖的?

当然是药物辅助的大规模共存啊。

等大家都有抗体了,当然给辉瑞默克面子,官方中断IVM。我要是印度总理,我也这么干。

楼主的95%抗体,可是支持我的推断的。
 
IVM工作已经完成了。看看曲线吧先。看看什么时候IVM开始发放,到9月中旬,病例数是不是已经触底。

你不想问问这中间发生了什么?

9月份抗体已经足够保护。印度当然不愿意得罪大厂。面子上要给。

而且实际上,你以为印度人买药需要向加拿大一样吗?

考虑问题要全面,不能停留在表面。

果然还是利港姐那句话,这一定是阴毛!刚才觉得圈儿还是要脸的。所以省略了。
结果说不出道道,还是真就搬出了阴毛论,那也没真啥好说的了。呵呵
 
最后编辑:
哈哈,我只是提供合理的解读,你去问问印度人买药,怎么买先。
 


有一种可能,

IVM用于感染初起,可以大幅度降低重症,死亡,

所以,IVM保驾,印度人慢慢都的过一遍了,但是并没有症状问题,所以印度没有显示出新的感染高峰。死亡更是大幅缩减。

这就是药物保护的共存的典型案例。

这一可能性是非常高的。

因为群免和疫苗都不是现在印度疫情低走的原因!


这都不能理解?

弱。

逻辑夸张到了时间错乱。你行。
呵呵,一直试图认真的和你进行技术讨论,现在看来好像难为你了。
 
哈哈,你搞清楚印度4/5月份的抗体%先.

还技术讨论, 你都时空错乱了. 好吧?
 
圈儿这个印度博主没好好做功课。印度早就不再推广 hcq / ivermectin。 因为没啥鸟用。 现在只限于 clinical trial

早说了,想当印度博主,先学会喝牛尿。不然就省省吧


IVM工作已经完成了。看看曲线吧先。看看什么时候IVM开始发放,到9月中旬,病例数是不是已经触底。

你不想问问这中间发生了什么?

9月份抗体已经足够保护。印度当然不愿意得罪大厂。面子上要给。

而且实际上,你以为印度人买药需要向加拿大一样吗?

考虑问题要全面,不能停留在表面。
逻辑能讲到这个地步,的确是无敌于天下了,以怕得罪大厂为由,连印度自己的报道也可以无视,完全可以随心所欲地解释任何数据和报道。

真是无耻之尤!

研究发现,HCQ 和伊维菌素对患者的 Covid 相关死亡率或临床康复几乎没有影响。

Why HCQ and Ivermectin were removed from India’s Covid-19 treatment protocol​


Ivermectin and HCQ were dropped from the clinical guidance after studies found that these drugs have little to no effect on Covid-related mortality or clinical recovery of the patient.


Sneha Mordani New DelhiSeptember 26, 2021UPDATED: September 26, 2021 07:18 IST



Studies have found that HCQ and Ivermectin have little to no effect on Covid-related mortality or clinical recovery of the patient. (PTI file photo)

The Indian Council of Medical Research (ICMR) and the National Task Force on Covid-19 have dropped the use of Ivermectin and Hydroxychloroquine (HCQ) drugs from their revised guidelines for the treatment of the infection.

The decision was taken after experts found that these drugs have little to no effect on Covid-related mortality or clinical recovery of the patient.

“HCQ may be considered for removal from guideline, with recommendation to use with caution only in clinical trial setting (since there is some genuine uncertainty regarding the possible benefit for severe cases and in low dose),” said the document titled ‘considerations for exclusion of Ivermectin and Hydroxychloroquine from the clinical guidance for management of adult Covid-19 patients’.

Several clinical studies have shown the low mortality benefit for HCQ, said the document. In fact, when HCQ is administered with azithromycin, it increases the risk of adverse drug effect (ADE) in patients, experts said.

ALSO READ | India reports 29,616 new Covid-19 cases in 24 hours, recovery rate highest since March 2020

Studies also found there was no clarity on mortality benefit, no effect on length of hospital stay and recovery in case of Ivermectin.

Recommending that Ivermectin be dropped from the clinical guidance, experts cited 13 systematic reviews of which “7/13 showed mortality benefit, 4/13 no mortality benefit, 2/13 inconclusive/unclear.”

Additionally, there was a high risk of bias in many of the studies, particularly with the ones showing mortality benefit, as the level of certainty is low in them.
The recommendations were made at a meeting of the All India Institute of Medical Sciences (AIIMS) and the ICMR national task force for Covid-19 and the Joint Monitoring Group on August 20.

ALSO READ | Covid-19: Maharashtra govt tells medical oxygen manufacturers to maintain stock at 95% capacity

Meanwhile, cautioning that the upcoming festival season is a critical period, AIIMS-Delhi Director Dr Randeep Guleria said the next 6-8 weeks are going to be critical and the community has to come together to ensure people follow all Covid norms and aggressively encourage vaccination.

While the number of new Covid-19 cases are steadily declining across the country, the Union Health Ministry has advised states and UTs to keep a strict vigil as the country is still in the midst of the second surge of the pandemic.

WATCH | 67% Indians have developed Covid-19 antibodies: Fourth sero survey
 
温哥华那个反疫苗的三哥不也是吃了ivm 最后还是挂了么……
 
五月为什么下跌?8月为什么取消IQ?因为研究发现IQ无效或很小。

Why HCQ and Ivermectin were removed from India’s Covid-19 treatment protocol​

Ivermectin and HCQ were dropped from the clinical guidance after studies found that these drugs have little to no effect on Covid-related mortality or clinical recovery of the patient.​

 
  • 喜欢
反馈: x5
这世上有一种病人,症状是接触ta的人都是病人。把CFC兵器榜前几号屏蔽了,这论坛看上去还蛮干净的,虽然是假象。
 
五月份为啥断崖?说说吧
 
后退
顶部